ロード中...
Surgery for Pancreatic Cancer after neoadjuvant treatment
Pancreatic ductal adenocarcinoma (PDAC) remains to be a therapeutic challenge as only 15%‐20% of all patients present with resectable tumor stages by the time of diagnosis. In the remaining patients, either local tumor extension or systemic spread are obstacles for a surgical therapy as the only cha...
保存先:
| 出版年: | Ann Gastroenterol Surg |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236102/ https://ncbi.nlm.nih.gov/pubmed/30460344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12203 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|